![<?echo $_SERVER['SERVER_NAME'];?>](/template/twentyseventeen/skin/images/header.jpg)
British researchers said on the 26th that they have grown into a kind of genetically modified purple tomato, which may have the effect of fighting cancer and some cardiovascular diseases.
The research team led by Kathy Martin, professor at John Innes Center, conducted the study. Previous studies have confirmed that anthocyanins can significantly slow down the growth of colon cancer cells, and at the same time have the effect of resisting cardiovascular diseases. Using the high anthocyanin content of snapdragons, the researchers transferred the two genes of this plant to ordinary tomatoes and developed a purple-colored tomato. This tomato has high anthocyanin content in its skin and fruit. In addition, dark berries such as blackberries, cranberries, and American plum are also higher in anthocyanins than other fruits. Tomato itself contains antioxidants such as lycopene and brassoids. The research team believes that the consumption of this transgenic purple tomato, which is rich in anti-cancer anthocyanins, will greatly benefit the reduction of cancer and other diseases.
However, Nutrition Nutritionist Anna Danny of the British Nutrition Foundation said that at this stage, humans have no “magic bullets†in the fight against cancer and heart disease. He suggested not to hold high expectations for the results of this experiment. "We should not completely replace balanced diets with fruits and vegetables that are rich in healthy compounds."